SLRX
Price
$4.71
Change
-$0.03 (-0.63%)
Updated
Sep 5 closing price
Capitalization
2.4M
UCBJF
Price
$246.34
Change
+$17.08 (+7.45%)
Updated
Sep 5 closing price
Capitalization
45.33B
Interact to see
Advertisement

SLRX vs UCBJF

Header iconSLRX vs UCBJF Comparison
Open Charts SLRX vs UCBJFBanner chart's image
Salarius Pharmaceuticals
Price$4.71
Change-$0.03 (-0.63%)
Volume$19.7K
Capitalization2.4M
UCB S.A
Price$246.34
Change+$17.08 (+7.45%)
Volume$161
Capitalization45.33B
SLRX vs UCBJF Comparison Chart in %
Loading...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCBJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLRX vs. UCBJF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLRX is a StrongBuy and UCBJF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (SLRX: $4.71 vs. UCBJF: $246.34)
Brand notoriety: SLRX and UCBJF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLRX: 8% vs. UCBJF: 8%
Market capitalization -- SLRX: $2.4M vs. UCBJF: $45.33B
SLRX [@Biotechnology] is valued at $2.4M. UCBJF’s [@Biotechnology] market capitalization is $45.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLRX’s FA Score shows that 0 FA rating(s) are green whileUCBJF’s FA Score has 2 green FA rating(s).

  • SLRX’s FA Score: 0 green, 5 red.
  • UCBJF’s FA Score: 2 green, 3 red.
According to our system of comparison, UCBJF is a better buy in the long-term than SLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLRX’s TA Score shows that 5 TA indicator(s) are bullish while UCBJF’s TA Score has 3 bullish TA indicator(s).

  • SLRX’s TA Score: 5 bullish, 2 bearish.
  • UCBJF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SLRX is a better buy in the short-term than UCBJF.

Price Growth

SLRX (@Biotechnology) experienced а -18.23% price change this week, while UCBJF (@Biotechnology) price change was +3.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UCBJF($45.3B) has a higher market cap than SLRX($2.4M). UCBJF YTD gains are higher at: 25.029 vs. SLRX (-82.935). UCBJF has higher annual earnings (EBITDA): 2.34B vs. SLRX (-5.18M). UCBJF has more cash in the bank: 2.01B vs. SLRX (111M). SLRX has less debt than UCBJF: SLRX (112K) vs UCBJF (2.88B). UCBJF has higher revenues than SLRX: UCBJF (6.85B) vs SLRX (0).
SLRXUCBJFSLRX / UCBJF
Capitalization2.4M45.3B0%
EBITDA-5.18M2.34B-0%
Gain YTD-82.93525.029-331%
P/E RatioN/A30.80-
Revenue06.85B-
Total Cash111M2.01B6%
Total Debt112K2.88B0%
FUNDAMENTALS RATINGS
SLRX vs UCBJF: Fundamental Ratings
SLRX
UCBJF
OUTLOOK RATING
1..100
1591
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
10021
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
9745
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UCBJF's Valuation (3) in the null industry is significantly better than the same rating for SLRX (88). This means that UCBJF’s stock grew significantly faster than SLRX’s over the last 12 months.

UCBJF's Profit vs Risk Rating (21) in the null industry is significantly better than the same rating for SLRX (100). This means that UCBJF’s stock grew significantly faster than SLRX’s over the last 12 months.

UCBJF's SMR Rating (91) in the null industry is in the same range as SLRX (100). This means that UCBJF’s stock grew similarly to SLRX’s over the last 12 months.

UCBJF's Price Growth Rating (45) in the null industry is somewhat better than the same rating for SLRX (97). This means that UCBJF’s stock grew somewhat faster than SLRX’s over the last 12 months.

UCBJF's P/E Growth Rating (99) in the null industry is in the same range as SLRX (100). This means that UCBJF’s stock grew similarly to SLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLRXUCBJF
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
25%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
39%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
43%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
34%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
46%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
45%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 10 days ago
56%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
27%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
38%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCBJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP9.150.41
+4.69%
Fortress Biotech
SKE17.300.55
+3.28%
Skeena Resources Limited
SSB103.01-0.54
-0.52%
SouthState Corp
MSB31.20-0.24
-0.76%
Mesabi Trust
FUSB12.01-0.13
-1.07%
First US Bancshares

SLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRX has been closely correlated with MBIO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLRX jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRX
1D Price
Change %
SLRX100%
-0.63%
MBIO - SLRX
71%
Closely correlated
-2.72%
PHIO - SLRX
41%
Loosely correlated
-0.97%
AZTR - SLRX
35%
Loosely correlated
-2.52%
NRSN - SLRX
32%
Poorly correlated
+7.27%
KNSA - SLRX
29%
Poorly correlated
+0.56%
More

UCBJF and

Correlation & Price change

A.I.dvisor indicates that over the last year, UCBJF has been loosely correlated with SHJBF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UCBJF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJF
1D Price
Change %
UCBJF100%
+7.45%
SHJBF - UCBJF
35%
Loosely correlated
N/A
GSGTF - UCBJF
23%
Poorly correlated
N/A
ONWRF - UCBJF
23%
Poorly correlated
N/A
VTVT - UCBJF
21%
Poorly correlated
-1.24%
SLRX - UCBJF
20%
Poorly correlated
-0.63%
More